slides · global inventory
Problem Statement Canvas
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,665
Current window 1,921-1,950
Pages 89
Rows per page 30
Tool
1,921-1,950 of 2,665
04
The slide uses a citation from Schroeder (2007) to validate the claim.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a split-screen layout with a quote on the left and data points on the right.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a molecular visualization of an antibody to illustrate the two functional arms of a T-cell engager.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Uses a rhetorical question to frame the company's value proposition as a paradigm shift.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a visual comparison between small molecule and biologic data availability to frame the problem.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
06
The slide uses a human silhouette to map clinical manifestations to specific body systems.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a biological process diagram showing intracellular vs plasma metabolism.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
23
The chart combines a bar chart of competitor benchmarks with a bar chart showing vedolizumab's exposure-response quartiles.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
42
The slide uses a Venn diagram to illustrate target overlap and a hierarchical tree to show potential combination therapy paths.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
26
This is a standard proxy statement slide used to defend against shareholder activism.Amazon | Shareholder Engagement Presentation Deck | 40 slides · Amazon
Shareholder letter Investor relations Loop · Voice Of Customer1 hit
25
The slide uses a biological map of the coronavirus genome to justify targeting nsp5 and nsp12.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
30
The concentric circles likely represent layers of risk or failure modes.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
08
Uses a timeline-style vertical flow to represent the 'need' metrics.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a vertical process flow to show the progression of clinical trials and data validation.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
22
The slide uses a dual-column layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' using a vertical process/list flow.ATAI | Investor Presentation Deck | 30 slides · atai
Pitch deck Investor relations Beat · TractionLoop · Golden Circle1 hit
29
The slide uses direct quotes from resignation and stockholder letters to build a case against the former directors.Cano Health | Investor Presentation Deck | 48 slides · Cano Health
Pitch deck Investor relations 1 hit
74
DocGo | Investor Day Presentation Deck | 119 slidesDocGo | Investor Day Presentation Deck | 119 slides · DocGo
Conference presentation Investor relations Beat · The Breakthrough1 hit
12
The slide uses a dark background with high-contrast text and a background image of lead-acid batteries to emphasize the 'toxic' nature of the product.Dragonfly Energy | Investor Presentation Deck | 24 slides · Dragonfly Energy
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Uses a visual flow with three circular icons representing the three main problem areas.Exscientia | Investor Presentation Deck | 45 slides · Exscientia
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
19
The slide uses a three-column structure to map biological challenges to design goals.Exscientia | Investor Presentation Deck | 45 slides · Exscientia
Conference presentation Investor relations 1 hit
08
The slide uses a background image of plastic pollution to emphasize the severity of the problem.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
Includes a screenshot of a press release as evidence of the enrollment milestone.MindMed | Investor Day Presentation Deck | 61 slides · MindMed
Conference presentation Investor relations Beat · Product1 hit
06
Uses a pictogram (4/5 dark blue) to visually represent the '1 in 5' statistic.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a visual process flow to contrast existing therapy failure with Nuvalent's solution.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a human anatomy diagram to map specific TRK receptor inhibition side effects to body regions.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
OKYO Pharma | Results Presentation Deck | 25 slidesOKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations Beat · Problem1 hit
22
Orbia | Investor Presentation Deck | 62 slidesOrbia | Investor Presentation Deck | 62 slides · Orbia
Conference presentation Investor relations Beat · Solution & Approach1 hit
13
The slide uses a combination of a big number metric and a list of qualitative pain points to frame the business problem.Rent The Runway | Results Presentation Deck | 34 slides · Rent The Runway
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
105
Uses a 'clipping' aesthetic to establish external validation of the problem.Tesla | Investor Day Presentation Deck | 163 slides · Tesla
Conference presentation Investor relations Beat · Action1 hit